## TRI: Thomson Reuters Corp - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.3% below STRENGTH zone (3.0-6.0%); PEG 12.15 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($125.93)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. TRI: Morgan Stanley Adjusts Price Target for Thomson Reuters | T**
- Source: GuruFocus | 20251217T180940 | Somewhat-Bearish | Relevance: 100%
- Morgan Stanley analyst Toni Kaplan has maintained an 'Equal-Weight' rating on Thomson Reuters (TRI) but reduced the price target from $172.00 to $165.00. This adjustment aligns with other recent analyst revisions for TRI, though the average analyst price target for the stock still implies a significant upside. Thomson Reuters is a major global provider of business information services, with key products like Westlaw and UltraTax CS.

**2. Morgan Stanley Adjusts Price Target for Thomson Reuters | TRI**
- Source: GuruFocus | 20251217T160920 | Somewhat-Bearish | Relevance: 100%
- Morgan Stanley analyst Toni Kaplan maintained an 'Equal-Weight' rating on Thomson Reuters (TRI) but lowered the price target from $172.00 to $165.00. This adjustment aligns with other recent analyst revisions for Thomson Reuters, a global provider of business information services. Despite the lowered target, Wall Street analysts project an average upside of 39.62% from the current price, with GuruFocus estimating an upside of 43.45% based on its GF Value.

**3. Thomson Reuters Corp (NASDAQ:TRI) Given Consensus Rating of "Strong Buy" by Brokerages**
- Source: MarketBeat | 20251217T120920 | Bullish | Relevance: 100%
- Thomson Reuters Corp (NASDAQ:TRI) has received a consensus "Strong Buy" rating from brokerages, with an average 12-month price target of $186.00. The company recently surpassed earnings and revenue estimates and has seen several major brokers upgrade its shares. Currently, the stock trades near $132.35, with a market capitalization of $58.9 billion.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $165 | $172 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 77.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 4 |

**Top Holders:**
- Woodbridge Co. Ltd: 67.6% (+0.0%)
- Royal Bank of Canada: 2.3% (-54.4%)
- Bank of Montreal /CA: 1.4% (+18.7%)
- Vanguard Group Inc: 1.3% (+1.3%)
- TD Asset Management,: 1.0% (-18.5%)

### Key Risks

1. Valuation stretched: PEG 12.2x requires aggressive growth execution.
2. Long-term trend broken: trading 23.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 12.15 signals overvaluation risk, limited margin of safety. Forward P/E 29.6x stretched relative to 14% growth. Quality metrics strong (margin 24%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bearish (4 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $59.5B |
| Beta | 0.31 |
| 52W Range | $128.16 - $218.42 |
| Short Interest | 0.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 12.15 |
| Forward P/E | 29.6 |
| Current P/E | 33.8 |
| YoY Growth | 14.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.8% to 0.3% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.7pp (needs >3.0% for momentum thesis). MRS_5 (-1.4%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.76x), long-term trend not supportive. MACD histogram positive (0.77), confirming momentum. OFD pattern: +DBH (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.30% (CS: 60) | Neutral |
| RSI_14 | 39.9 | Neutral |
| MACD Histogram | 0.77 | Bullish |
| vs SMA20 | 0.994x | Below |
| vs SMA50 | 0.923x | Below |
| vs SMA200 | 0.763x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $131.63
- **Stop Loss:** $125.93 (4.3% risk)
- **Target:** $137.33 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 157
- **Position Value:** $20,665.91
- **Portfolio %:** 20.67%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-05 (Est: $1.07)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.83 | $0.85 | +2.9% |
| 2025Q2 | $0.83 | $0.87 | +4.6% |
| 2025Q1 | $1.04 | $1.12 | +7.3% |
| 2024Q4 | $0.96 | $1.01 | +5.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*